OR WAIT null SECS
© 2021 MJH Life Sciences and Formulary Watch. All rights reserved.
© 2021 MJH Life Sciences™ and Formulary Watch. All rights reserved.
October 26, 2021
The label now includes new data from the trial that supported Cyltezo’s application for interchangeability with Humira.
October 24, 2021
October 20, 2021
Glass was found in one vial of Cubicin, which treats patients with Staph infections of the skin and blood.
October 17, 2021
October 14, 2021
The product contained N-nitrosoirbesartan impurity, a probable human carcinogen.
Hikma, which makes the broad-spectrum antibiotic, has experienced manufacturing delays.
October 10, 2021
October 06, 2021
The labeling of Trikafta, which treats cystic fibrosis, has been updated to warn about the possibility of liver failure that could lead to the need for transplantation.
October 04, 2021
The labeling for selective serotonin reuptake inhibitors (SSRIs) and selective serotonin-norepinephrine reuptake Inhibitors (SSNRIs) now must include information about sexual side effects in the warning and precautions and patient counseling sections.
October 03, 2021